Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Brugia malayi | flavodoxin family protein | 0.0136 | 0.5677 | 0.5677 |
Trypanosoma cruzi | p450 reductase, putative | 0.0136 | 0.5677 | 1 |
Schistosoma mansoni | NADPH flavin oxidoreductase | 0.0068 | 0.1115 | 0.0151 |
Loa Loa (eye worm) | FAD binding domain-containing protein | 0.0084 | 0.216 | 0.216 |
Chlamydia trachomatis | sulfite reductase | 0.0084 | 0.216 | 0.5 |
Entamoeba histolytica | type A flavoprotein, putative | 0.0052 | 0 | 0.5 |
Plasmodium falciparum | nitric oxide synthase, putative | 0.0136 | 0.5677 | 1 |
Trypanosoma cruzi | cytochrome P450 reductase, putative | 0.0136 | 0.5677 | 1 |
Trichomonas vaginalis | NADPH fad oxidoreductase, putative | 0.0121 | 0.4632 | 0.8159 |
Trypanosoma brucei | NADPH--cytochrome P450 reductase, putative | 0.0136 | 0.5677 | 1 |
Toxoplasma gondii | flavodoxin domain-containing protein | 0.0067 | 0.1045 | 0.5 |
Trypanosoma cruzi | cytochrome P450 reductase, putative | 0.0136 | 0.5677 | 1 |
Trypanosoma brucei | NADPH-dependent diflavin oxidoreductase 1 | 0.0136 | 0.5677 | 1 |
Giardia lamblia | Hypothetical protein | 0.0121 | 0.4632 | 0.5 |
Giardia lamblia | Nitric oxide synthase, inducible | 0.0121 | 0.4632 | 0.5 |
Toxoplasma gondii | flavodoxin domain-containing protein | 0.0067 | 0.1045 | 0.5 |
Entamoeba histolytica | type A flavoprotein, putative | 0.0052 | 0 | 0.5 |
Trypanosoma cruzi | NADPH-dependent FMN/FAD containing oxidoreductase, putative | 0.0136 | 0.5677 | 1 |
Entamoeba histolytica | type A flavoprotein, putative | 0.0052 | 0 | 0.5 |
Loa Loa (eye worm) | receptor family ligand binding region containing protein | 0.02 | 1 | 1 |
Trypanosoma brucei | NADPH--cytochrome P450 reductase, putative | 0.0136 | 0.5677 | 1 |
Leishmania major | p450 reductase, putative | 0.0136 | 0.5677 | 1 |
Leishmania major | cytochrome P450 reductase, putative | 0.0121 | 0.4632 | 0.8159 |
Mycobacterium ulcerans | formate dehydrogenase H FdhF | 0.0136 | 0.5677 | 0.5 |
Brugia malayi | FAD binding domain containing protein | 0.0084 | 0.216 | 0.216 |
Trypanosoma brucei | NADPH-cytochrome p450 reductase, putative | 0.0136 | 0.5677 | 1 |
Schistosoma mansoni | 5-methyl tetrahydrofolate-homocysteine methyltransferase reductase | 0.0084 | 0.216 | 0.2407 |
Loa Loa (eye worm) | FAD binding domain-containing protein | 0.0136 | 0.5677 | 0.5677 |
Plasmodium vivax | flavodoxin domain containing protein | 0.0121 | 0.4632 | 0.8159 |
Brugia malayi | FAD binding domain containing protein | 0.0136 | 0.5677 | 0.5677 |
Trichomonas vaginalis | sulfite reductase, putative | 0.0136 | 0.5677 | 1 |
Entamoeba histolytica | type A flavoprotein, putative | 0.0052 | 0 | 0.5 |
Leishmania major | NADPH-cytochrome p450 reductase-like protein | 0.0136 | 0.5677 | 1 |
Treponema pallidum | flavodoxin | 0.0052 | 0 | 0.5 |
Schistosoma mansoni | cytochrome P450 reductase | 0.0136 | 0.5677 | 1 |
Echinococcus multilocularis | NADPH dependent diflavin oxidoreductase 1 | 0.0136 | 0.5677 | 1 |
Echinococcus multilocularis | NADPH cytochrome P450 reductase | 0.0136 | 0.5677 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0136 | 0.5677 | 0.5677 |
Echinococcus granulosus | NADPH dependent diflavin oxidoreductase 1 | 0.0136 | 0.5677 | 1 |
Echinococcus granulosus | NADPH cytochrome P450 reductase | 0.0136 | 0.5677 | 1 |
Entamoeba histolytica | type A flavoprotein, putative | 0.0052 | 0 | 0.5 |
Plasmodium vivax | NADPH-cytochrome p450 reductase, putative | 0.0136 | 0.5677 | 1 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
ED30 (functional) | > 20 uM | Dose required for 30% clonal survival of ER positive MCF-7 breast cancer cells after 2 hr | ChEMBL. | 15203171 |
ED30 (functional) | > 20 uM | Dose required for 30% clonal survival of ER negative MDA-MB231 breast cancer cells after 2 hr | ChEMBL. | 15203171 |
logD (ADMET) | = 3.12 | LogD of the compound was determined at pH 7.4 | ChEMBL. | 15203171 |
logP (ADMET) | = 6.27 | Partition coefficient (logP) | ChEMBL. | 15203171 |
Oligo modified (functional) | = 29 % | Percent of 16-mer cleaved by piperidine after treatment with test compound for 24 h at 37 degrees C | ChEMBL. | 15203171 |
Oligo shifted (functional) | = 93 % | Percent of covalently modified 16-mer (DNA adduct) in a slowly migrating complex with ER ligand binding domain (ER-LBD) in EMSA electrophoretic mobility shift assay | ChEMBL. | 15203171 |
RBA (binding) | = 10 | Relative binding affinity for rabbit uterine estrogen receptor compared to estradiol | ChEMBL. | 15203171 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.